疏肝和胃方联合奥美拉唑治疗肝胃郁热型非糜烂性胃食管反流病的疗效分析

Efficacy of the Shugan Hewei prescription plus omeprazole on non-erosive reflux disease of the Ganwei Yure type

目的:分析疏肝和胃方联合奥美拉唑治疗肝胃郁热型非糜烂性胃食管反流病的疗效。方法:将我院门诊就诊的72例肝胃郁热型非糜烂性胃食管反流病患者作为研究对象,并随机分组,观察组给予疏肝和胃方联合奥美拉唑治疗,对照组给予奥美拉唑治疗。比较两组疗效、复发率、不良反应。结果:观察组总有效率优于对照组,治疗后8周时,观察组复发率低于对照组,差异显著(P<0.05);观察组、对照组皆未出现药物相关性不良反应,差异不显著(P>0.05),差异无统计学意义,有可比性。结论:疏肝和胃方联合奥美拉唑治疗肝胃郁热型非糜烂性胃食管反流病的疗效显著,值得应用推广。

Objective： To analyze the efficacy of the Shugan Hewei prescription（疏肝和胃方） plus omeprazole on non-erosive refluxdisease of the Ganwei Yure type（ 肝胃郁热型）. Methods： 72 cases were selected and divided into two groups. The observation group was given the Shugan Hewei prescription plus omeprazole; and the control group was given omeprazole. Results： The total efficiency in the observation group was better than the control group. After 8 weeks, the recurrence rate in the observation group was lower（P〈0.05）. No drug-related adverse reactions occurred in the observation group and the control group（P〉0.05）. Conclusion： The Shugan Hewei prescription plus omeprazole on non-erosive reflux disease of the Ganwei Yure type was effective, and is worthy of application and promotion.